Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pethidine bulk supplier for pharma manufacturers

Pethidine 50 mg/ ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/ ml

Reference Brands: Available in generic

Category: Analgesic

Pethidine is a pain relieving medicine. It effectively alleviates moderate to severe pain.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

-

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

PharmaTradz lists GMP-certified manufacturers, suppliers and exporters of Pethidine (reference brands: Available in generic). Post an RFQ to receive quotes from verified suppliers with export experience.

Pethidine is available as Injection in 50 mg/ ml. Availability for your market is confirmed at RFQ stage.

Yes — suppliers on PharmaTradz support bulk export with regulatory documentation such as COA, GMP certificates and CTD/ACTD dossiers where available. Share your destination market in your RFQ and we match you to suppliers able to serve it.

Related Products

Sulindac

Strength:
150 mg, 200 mg

Form: Tablets

Reference Brands: Clinoril (USA/EU)

View Details
Orphenadrine Citrate

Strength:
100 mg, 60 mg/mL, 30 mg/mL

Form: Tablets / injection

Reference Brands: Norflex (USA), Orphenate (USA)

View Details
Methocarbamol

Strength:
500 mg, 750 mg

Form: Tablet / Injection

Reference Brands: Robaxin (USA/EU), Carbacot (USA/EU)

View Details
Metaxalone

Strength:
800 mg

Form: Tablets

Reference Brands: Skelaxin (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.